Biocompatibles has announced the filing for CE Mark approval by the Company’s development and marketing partner Merz Pharmaceuticals GmbH for the Cosmetic Dermal Filler Bead. The product has been licensed to Merz and will be manufactured by Biocompatibles’ German subsidiary, CellMed AG. The global market for aesthetic dermal filler products1 is at least $760m2. The current market consists mainly of products manufactured from collagen and hyaluronic acid. Biocompatibles’ subsidiary CellMed manufactures the Cosmetic Dermal Filler Bead from highly purified alginate material, using a proprietary manufacturing process.

Stiefel Laboratories has announced the expansion of its REVALESKIN skin care line with three new products on the heels of the extraordinarily successful introduction of the core REVALESKIN(R) skin care system (Facial Cleanser, Day Cream with SPF 15 sunscreen and Night Cream). According to a Global Industry Analysis Report (March 2008), the market for anti-aging products is predicted to reach $115.5 billion by 2010. With the launch of these three new products, the REVALESKIN(R) skin care line will meet consumer demand for professional take-home beauty products designed for targeted treatment of problem skin areas.